ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

NCI News: Biospecimen Banks Program for NCTN

November 22, 2013

Gore Proposes New War On cancer, Double research Funding Over 5 years

July 9, 1999

Coalition Of Cooperative Groups Lists High Priority Trials In Breast Cancer.

October 17, 2008

Opening Shots Fired In 10 Year Defense of Cancer Program, Launching Of Effort To Continue, Expand It

September 19, 1980

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993